GLP-1 Market
LLY $1123.00 ▼ -0.1% NVO $44.01 ▼ -1.2% PFE $27.65 ▼ -0.5% VKTX $32.13 ▼ -1.7% KLRA $14.91 ▲ +0.5% GPCR $39.55 ▼ -4.1% RHHBY $53.19 ▼ -0.4% HIMS $27.44 ▼ -1.6% WW $14.78 ▼ -1.1%
Delayed · As of 9:20 AM

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

SAP-001

Company
Shanton Pharma Co., Ltd.
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
None currently listed

Efficacy results: Not yet reported

No recruiting studies currently listed

See all studies for this drug

Data source: ClinicalTrials.gov · trial data as of Sep 11, 2026

Trial details
  • Completed NCT NCT03857165

    Placebo Controlled, Dose Escalation Study to Evaluate Safety, Pharmacokinetics & Efficacy of SAP-001 in Gout Patients

    Not yet reported Shanton Pharma Co., Ltd. 24 participants Est. completion 2019-10-31 3 sites Stand-alone
    Other conditions: Gout, Hyperuricemia
    View official trial listing →
  • Completed NCT NCT04040816

    Placebo Controlled, Multiple Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAP-001 in Gout Patients

    Not yet reported Shanton Pharma Co., Ltd. 40 participants Est. completion 2020-08-30 6 sites Stand-alone
    Other conditions: Gout, Hyperuricemia
    View official trial listing →
  • Active, not recruiting NCT NCT05690204

    Dose Finding Study to Evaluate Safety and Efficacy of 3 Dosages of SAP 001.

    Not yet reported Shanton Pharma Pte. Ltd. 87 participants Est. completion 2025-02 16 sites Stand-alone
    Other conditions: Gout
    View official trial listing →
  • Completed NCT NCT06678581

    SAD,MAD and Food Effect Study of SAP-001 Tablets in Chinese Subjects

    Not yet reported Shanton Pharma Co., Ltd. 70 participants Est. completion 2024-01-11 1 site Stand-alone
    Other conditions: Gout, Hyperuricemia
    View official trial listing →
  • Active, not recruiting NCT NCT06729853

    PK and Safety Evaluation Study of SAP-001 in Adult Subjects With Normal and Impaired Renal Function

    Not yet reported, Not yet reported Shanton Pharma Pte. Ltd. 32 participants Est. completion 2025-04-28 2 sites Stand-alone
    Other conditions: Gout, Hyperuricemia
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.